ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 70 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 4.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $62,000 | +37.8% | 36,600 | 0.0% | 0.00% | – |
| Q4 2020 | $45,000 | -13.5% | 36,600 | 0.0% | 0.00% | – |
| Q3 2020 | $52,000 | -38.8% | 36,600 | -48.2% | 0.00% | – |
| Q2 2020 | $85,000 | +107.3% | 70,600 | +104.6% | 0.00% | – |
| Q1 2020 | $41,000 | -8.9% | 34,500 | +61.2% | 0.00% | – |
| Q4 2019 | $45,000 | -4.3% | 21,400 | 0.0% | 0.00% | – |
| Q3 2019 | $47,000 | -13.0% | 21,400 | 0.0% | 0.00% | – |
| Q2 2019 | $54,000 | -1.8% | 21,400 | +50.7% | 0.00% | – |
| Q1 2015 | $55,000 | +14.6% | 14,200 | +97.2% | 0.00% | – |
| Q4 2014 | $48,000 | -35.1% | 7,200 | -46.3% | 0.00% | – |
| Q3 2014 | $74,000 | -46.0% | 13,400 | 0.0% | 0.00% | – |
| Q2 2014 | $137,000 | – | 13,400 | +60809.1% | 0.00% | – |
| Q1 2014 | $0 | -100.0% | 22 | -97.3% | 0.00% | – |
| Q4 2013 | $9,000 | -96.2% | 822 | -96.3% | 0.00% | – |
| Q3 2013 | $239,000 | +8.1% | 22,222 | -6.6% | 0.00% | – |
| Q2 2013 | $221,000 | – | 23,805 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,528,120 | $38,210,000 | 1.53% |
| Cormorant Asset Management, LP | 850,000 | $2,593,000 | 0.41% |
| Palo Alto Investors LP | 1,656,644 | $5,053,000 | 0.24% |
| Granahan Investment Management | 1,745,604 | $5,324,000 | 0.16% |
| Spark Investment Management LLC | 318,500 | $980,000 | 0.13% |
| Opus Point Partners Management, LLC | 57,747 | $176,000 | 0.10% |
| SHEPHERD KAPLAN KROCHUK, LLC | 76,472 | $233,000 | 0.06% |
| Joel Isaacson & Co., LLC | 70,660 | $216,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $229,000 | 0.05% |
| Cornerstone Capital, Inc. | 59,200 | $181,000 | 0.04% |